---
title: "Grand Pharmaceutical Says Imaging Agent Accepted For Chinese Regulatory Review"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/272962693.md"
description: "Grand Pharmaceutical Says Imaging Agent Accepted For Chinese Regulatory Review"
datetime: "2026-01-19T10:44:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272962693.md)
  - [en](https://longbridge.com/en/news/272962693.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272962693.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/272962693.md) | [繁體中文](https://longbridge.com/zh-HK/news/272962693.md)


# Grand Pharmaceutical Says Imaging Agent Accepted For Chinese Regulatory Review



### 相关股票

- [GRAND HOLDING (000626.CN)](https://longbridge.com/zh-CN/quote/000626.CN.md)
- [HUADONG MEDICINE (000963.CN)](https://longbridge.com/zh-CN/quote/000963.CN.md)

## 相关资讯与研究

- [14:00 ETAn InventHelp 123Invent Client Develops Smart Bathtub Fixtures (HOF-668)](https://longbridge.com/zh-CN/news/278925154.md)
- [04:00 ETTARRAN lanza la primera bicicleta de cola larga hiperintegrada](https://longbridge.com/zh-CN/news/278842863.md)
- [09:05 ETWOODY'S BRANDS EXPANDS IN GREATER HOUSTON WITH NEW WOODY'S HIDEAWAY IN WEBSTER](https://longbridge.com/zh-CN/news/278562535.md)
- [Lundbeck completes patient randomisation early in global MSA trial](https://longbridge.com/zh-CN/news/278374508.md)
- [ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug](https://longbridge.com/zh-CN/news/278415109.md)